ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 118 filers reported holding ALLAKOS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,413,987 | -48.5% | 8,552,417 | -1.2% | 0.52% | -50.1% |
Q2 2023 | $37,724,538 | +39.9% | 8,652,417 | +42.8% | 1.05% | +6.6% |
Q1 2023 | $26,968,099 | -36.0% | 6,060,247 | +21.0% | 0.99% | -44.6% |
Q4 2022 | $42,158,275 | +37.6% | 5,006,921 | 0.0% | 1.78% | +40.5% |
Q3 2022 | $30,642,000 | – | 5,006,921 | – | 1.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |